To study the interactions between CML and immune cells, we profiled CD34+ and CD34 + CD38- populations from 3 additional diagnostic phase CML patients’ bone marrow samples. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.